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ABSTRACT
INTEGRIN INHIBITOR CYCLORGDN BLUNTS ENHANCED LPS-INDUCED LIVER INJURY
CAUSED BY ETHANOL IN MICE

Veronica L. Massey
11/15/2012

Background. Progression of alcoholic liver disease (ALD) is associated with an increase
in fibrin extracellular matrix (ECM) and inflammation. Previous studies have shown that this
accumulation of fibrin in ALD is mediated by impaired fibrinolysis. Additionally, it is known that
fibrin(ogen) interacts with the

av~3

integrin of endothelial cells. The purpose of this study was to

test the hypothesis that hepatic inflammation caused by alcohol is mediated, at least in part, by
activation of integrin

av~3

by fibrin(ogen). To test this hypothesis, a study was designed to

determine the effect of cycloRGDN, a peptide inhibitor of integrin

av~3,

in a mouse model of

lipopolysaccharide (LPS)-induced inflammation enhanced by ethanol pre-exposure. Methods.
Accordingly, male C57BLl6J mice were exposed to ethanol (6 g/kg i.g.) or isocaloriclisovolumetric
maltose dextrin solution for 3 days and injected with lipopolysaccharide (LPS; 10 mg/kg i.p.) 24
hours after the last dose of ethanol. Some animals received the

av~3

integrin inhibitor

(cycloRGDN; 3 mg/kg i.p.) 1 hour prior to LPS administration. Animals were sacrificed 8 or 24
hours after LPS administration. Liver damage was assessed by plasma (AL T, AST) and
histological indices of liver damage (hematoxylin and eosin; H&E) and inflammation
(chloroacetate esterase; CAE). Results. Ethanol pre-exposure enhanced liver injury due to LPS,
as indicated by a significant increase in plasma ALT levels. cycloRGDN significantly attenuated
the increase in plasma AL T caused by ethanol pre-exposure. These results were supported by
histological changes. Animals that received ethanol and LPS had both larger and more
numerous necroinflammatory foci compared to animals that received LPS alone. The number

v

and severity of necroinflammatory foci was reduced by cycloRGDN compared to LPS + ethanol.
Ethanol pre-exposure enhanced the increase in neutrophil migration caused by LPS, as
determined by CAE staining. Animals administered cycloRGDN had fewer infiltrating neutrophils
compared to those that received a combination of ethanol and LPS. Conclusions. These data
suggest that cycloRGDN administration protects against liver injury caused by a combination of
alcohol and LPS exposure. CycloRGDN also blunts ethanol-enhanced neutrophil infiltration
caused by LPS in this model. Therefore, integrin av~3 may play an important role in enhanced
hepatic inflammation and injury due to LPS after ethanol pre-exposure.
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INTRODUCTION

Alcoholic liver disease (ALD) affects more than 10 million Americans a year at a cost of more
than $166 billion annually to treat the medical consequences of alcohol abuse(1). ALD is a
spectrum of disease states that includes steatosis, steatohepatitis, and fibrosis and cirrhosis.
Steatosis is the least severe stage of disease, characterized by fat accumulation in the liver. In
some cases, continued alcohol consumption results in development of steatohepatitis, a disease
state distinguished by chronic inflammation and the persistence of accumulated fat. The most
severe stages of alcoholic liver disease include fibrosis and cirrhosis, which are characterized by
collagen matrices and regenerative nodules, respectively. Despite the vast amount of money
spent on treating alcoholic liver disease, therapeutic options are limited to palliative care, as no
Food and Drug Administration (FDA)-approved therapy currently exists to halt or reverse disease
progression. If a rational targeted therapy is to be developed, currently accepted mechanisms
behind disease progression must be better understood and novel targets identified.
The mechanisms involved in the various stages of alcohol-induced liver injury have been
extensively investigated using animal models that recapitulate the specific stages of the disease
(i.e., steatosis, inflammation and fibrosis). However, the mechanisms behind progression of ALD
from earlier stages (i.e., steatosis) to later stages (i.e., steatohepatitis), remain unclear although
critical to our understanding of how to blunt progression. 2-hit models of alcohol-induced liver
injury can be used to study inflammatory injury due to alcohol. In such models, alcohol serves as
a 'first hit' that sensitizes the liver to a 'second hit' such as lipopolysaccharide (LPS) resulting in
organ injury. For example, the acute ethanol 2-hit model of alcohol-induced liver injury and
inflammation is characterized by enhanced lipopolysaccharide (LPS)-induced liver injury and
inflammation caused by alcohol pre-exposure (2). This acute alcohol exposure model has been
used to show that fibrin deposition strongly correlates to enhanced LPS-induced liver injury and
inflammation in mice. Furthermore, blocking fibrin accumulation protected against enhanced liver
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injury and inflammation caused by alcohol in this model. Other studies have shown that fibrin
accumulation is an early change during chronic alcohol exposure (Arteel et ai, unpublished data).
These data implicate fibrin as an important player in enhanced inflammation and injury caused by
acute alcohol exposure. Fibrin(ogen) is a structural component of the extracellular matrix (ECM)
regulated by the coagulation cascade. Fibrin's role in inflammation has been highlighted by its
ability to exert a myriad of inflammatory effects. For example, Qi and colleagues showed that
fibrin induces IL-8 expression by vascular endothelial cells (3). Fibrin matrices also enhance
migration of inflammatory cells in vitro, including IL-8 stimulated neutrophils (4). Whereas fibrin's
pro-inflammatory effects are well documented, the mechanism by which this extracellular matrix
component mediates these effects remains unclear.
Fibrin matrices could mediate inflammatory effects either via their structural role as a
component of the ECM or by acting as signaling molecules. Fibrin serves as a ligand of the
integrin family of cell surface adhesion receptors, particularly the integrin ov133 (5). Integrins are
heterodimeric receptors expressed on many cell types, including endothelial cells, inflammatory
cells including macrophages and neutrophils, and platelets (6). Integrins are a diverse
superfamily with at least 24 different heterodimers that are important in a variety of cell processes
including proliferation (7), angiogenesis (8, 9), and inflammation (10). Upon interaction with
extracellular components, such as fibrin, the 13 subunit of an integrin can undergo a rapid
conformational change. This change in integrin structure allows for transfer of information across
the plasma membrane by activation of intracellular signaling pathways. Adaptor proteins, such as
integrin linked kinase (ILK), paxillin and focal adhesion kinase (FAK), are important mediators in
signal transduction downstream of integrin activation and playa role in specifying which signaling
cascades are activated within the cell (11-15). Owing to their myriad of effects on growth,
angiogenesis and inflammation, integrin inhibitors have been investigated for therapeutic use.
For example, small peptide inhibitors of integrins, including integrins 04131, 04137, and ov133 are
currently in clinical trial for treatment of asthma, chronic obstructive pulmonary disease (16), and
certain types of cancer (17).
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The role of integrin
stimulation of integrin

av~3

av~3

in tumor angiogenesis and metastasis is well documented and

also has been shown to contribute to inflammation (18). Integrin

av~3

is strongly expressed by endothelial cells (19) including those that line the hepatic sinusoids
where fibrin accumulates after alcohol exposure. Moreover, integrin
correlated temporally to fibrin deposition (20). Integrin

av~3

av~3

expression has been

binds fibrin(ogen) via an arginine-

glycine-aspartic acid (RGO) sequence on the fibrin molecule (5), allowing the interaction between
fibrin and this integrin to be studied using small, commercially available peptide antagonists (21).
The experiments described here were performed to test the hypothesis that hepatic
inflammation caused by alcohol is mediated, at least in part, by activation of integrin

av~3

by

fibrin(ogen). The goal of this study was to determine the effect of a peptide inhibitor of integrin
av~3,

cycioRGON, in an acute ethanol 2-hit mouse model of hepatic inflammatory injury.
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MATERIALS AND METHODS

Animals and Treatments
Eight week old male C57BU6J mice were purchased from the Jackson Laboratory (Bar
Harbor, ME). Mice were housed in a pathogen-free barrier facility accredited by the Association
for Assessment and Accreditation of Laboratory Animal Care, and procedures were approved by
the University of Louisville's Institutional Animal Care and Use Committee. Food and tap water
were provided ad libitum. Mice received ethanol (6 g/kg i.g.) or isocaloric/isovolumetric maltosedextrin solution for 3 days and were injected with LPS (E. coli, serotype 055:B5; Sigma, St. Louis,
MO; 10 mg/kg i. p.) 24 hours after the last dose of ethanol (2) (Figure 1) . The av133 integrin
inhibitor cycioRGON (Enzo Life Sciences, Plymouth Meeting, PA; 3 mg/kg i.p.) or vehicle (PBS)
was injected 1 hour prior to LPS administration. Animals were anesthetized with
ketamine/xylazine (100/15 mg/kg, i.m.) 8 or 24 hours after LPS administration. Blood was
collected from the vena cava just prior to sacrifice by exsanguination and citrated plasma was
stored at -80 DC for further analysis. Portions of liver tissue were snap-frozen in liquid nitrogen,
frozen-fixed in OCT-Compound (Sakura Finetek, Torrance, CA), or were fixed in 10% neutral
buffered formalin for subsequent sectioning and mounting on microscope slides.

Clinical Chemistry and Pathologic Evaluation
Levels of alanine aminotransferase (AL T) and aspartate aminotransferase (AST) were
determined spectrophotometrically using standard kits (Thermotrace, Melbourne, Australia).
Plasma hyaluronic acid (HA) was quantitated using an ELISA kit (Corgenix, Broomfield, CO).
Formalin fixed, paraffin embedded sections were cut at 5 IJm and mounted on glass slides.
Sections were deparaffinized and stained with hematoxylin and eosin (H&E). Chloroacetate
esterase (CAE) staining for neutrophils was performed using the naphthol AS-O chloroacetate
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Figure 1

Sacrifice

i

24 hours

Figure 1: Acute ethanol 2-hit model of liver injury.
Mice received a dose of ethanol (6 g/kg i.g .) or isocaloric/isovolumetric maltosedextrin solution for 3 d and were injected with LPS (10 mg/kg i.p.) or vehicle
(saline) 24 hours after the last dose of ethanol or control diet. The avj33 integrin
inhibitor cycioRGON (3 mg/kg i. p.) or vehicle (PBS) was injected 1 hour prior to
LPS administration .
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esterase kit (Sigma, St. Louis, MO) on paraffin embedded samples. The extent of CAE staining
was quantified by blinded counting of CAE-positive neutrophils per 1000 hepatocytes (22). CAEpositive cells counted during quantification were characterized by light pink (i.e. CAE-positive)
staining and bi-Iobed nuclear morphology.

RNA Isolation and Quantitative Reverse-Transcriptase Polymerase Chain Reaction
The hepatic mRNA expression of select genes was detected by quantitative reversetranscriptase polymerase chain reaction (rt-PCR), which is routine for this group (2, 23-25).
primers and probes for TN Fa, PAI-1, IL-6, IL-10 and

~-actin

PCR

were designed using Primer 3

(Whitehead Institute for Biomedical Research, Cambridge, MA). Primers and probes for CD31,
integrin av, integrin

~3,

C-fos, C-myc, and SOCS3 were bought from Applied Biosystems as kits

(Foster City, CA). All primers were designed to cross introns to ensure that only cDNA and not
genomic DNA was amplified.

Total RNA was extracted from liver tissue by a guanidinium

thiocyanate-based method (RNA STAT 60 Tel-Test, Ambion, Austin, TX). RNA concentrations
were determined spectrophotometrically and 1 IJg of total RNA was reverse transcribed using a
kit (Quanta Biosciences, Gaithersburg, MD). PerfeCta qPCR Fast Mix (Quanta Biosciences,
Gaithersburg, MD) was used to prepare the PCR reaction mixture. This 2X mixture is optimized
for TaqMan reactions and contains MgCI 2 , dNTPs, and AccuFast Taq DNA Polymerase.
Amplification reactions were carried out using the ABI StepOne Plus machine and software
(Quanta Biosciences, Gaithersburg, MD) with initial holding stage (95°C for 30 seconds) and 50
cycles of a 2-step PCR (95°C for 30 seconds, 60°C for 20 seconds).

Fluorescent intensity of

each sample was measured at each cycle to monitor amplification of the target gene. The
comparative CT method was used to determine fold changes in mRNA expression compared to
an endogenous reference gene

(~-actin).

This method determines the amount of target gene,

normalized to an endogenous reference and relative to a calibrator (2-

Immunostaining
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).

For immunofluorescent detection of the platelet endothelial cell adhesion molecule
(CD31), formalin-fixed, paraffin-embedded sections (5IJm) were deparaffinized and then
rehydrated with graded ethanol solutions. Slides were incubated in primary antibody for CD31
(Abcam, Cambridge, MA). A secondary antibody, goat anti-rat Alexa 488-lgG was used
(Invitrogen, Carlsbad, CA). Samples were mounted and counterstained with Vectashield with
DAPI (Vector laboratories, Burlingame, CA).

Immunofluorescent detection of fibrin deposition

was performed as described in (22). Briefly, frozen liver sections (6 IJm thick) were fixed in 10%
buffered formalin containing 2% acetic acid to solubilize all but cross-linked fibrin. Sections were
blocked with PBS containing 10% horse serum before an overnight incubation at 4°C with affinity
purified rabbit anti-human fibrionogen IgG (Dako North America, Inc. Carpinteria, CA) diluted in
blocking solution. Donkey anti-rabbit antibody conjugated to Alexa 488 (Invitrogen, Carlsbad,
CA) was used as secondary antibody. Tissue was counterstained with Hoechst. Fluorescence
for Alexa 488 and Hoechst was detected at excitation and emission wavelengths of 490 nm and
520 nm, and 350 nm and 460 nm, respectively. Immunofluorescence was visualized using a
Nikon Eclipse E600 microscope (Nikon Corporation, Tokyo, Japan) and Metamorph software.

Immunoblots
All buffers used for protein extraction contained protease, tyrosine phosphatase, and
serine-threonine phosphate inhibitor cocktails (Sigma, St. louis, MO). Liver samples were
homogenized in CHAPs buffer (50 mM Tris/CI, pH 7.4,5 mM EDTA, 5 mM EGTA, 1% (w/v)
PMSF). Homogenized samples were loaded onto SDS-polyacrylamide gels containing 10% (w/v)
acrylamide, followed by electrophoresis and Western blotting onto nitrocellulose membranes
(Hybond P, GE Healthcare, Piscataway, NJ). Primary antibodies against phosphorylated and
total extracellular-signal-regulated kinases 1 and 2 (ERK1/2), c-Jun N-terminal kinases 1 and 2
(JNK1/2), signal tranducer and activator of transcription 3 (STAT3), focal adhesion kinase (FAK),
and paxillin (Cell Signaling Technology, Beverly, MA) were used. Bands were visualized using an
ECl kit (Pierce, Rockford, Il) and Hyperfilm (GE Healthcare, Piscataway, NJ). Densitometric
analysiS was performed using UN-SCAN-IT Gel (Silk Scientific, Orem, UT) software.
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Statistical Analyses

Results are reported as means ± standard error mean (SEM; n

=4-7).

ANOVA with

Bonferroni's post-hoc test (for parametric data) or Mann-Whitney Rank Sum test (for
non parametric data) was used for the determination of statistical significance among treatment
groups, as appropriate. A p value less than 0.05 was selected before the study as the level of
significance.
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RESULTS

Hepatic integrin expression and fibrin deposition.

The purpose of these studies was to investigate the role of integrins in mediating the proinflammatory effects of fibrin in the pre-fibrotic phase of alcoholic liver disease (ALD). Therefore,
it was necessary to verify that the effects of cycloRGDN administration were not due to changes
in hepatic integrin expression or fibrin accumulation in the liver. To determine effects on integrin
expression, quantitative rt-PCR was performed for the av and

~3

integrin subunits. LPS alone did

not significantly affect hepatic mRNA levels of either the av or

~3

integrin subunits (Figure 2).

The combination of ethanol and LPS significantly increased levels of integrin av and

~3

integrin

subunit mRNA expression (by -2-fold and -1.4 fold, respectively) compared to LPS alone and
naIve controls, respectively. CycloRGDN did not have a significant effect on the mRNA
expression of either integrin subunit.
The effect of LPS and ethanol on hepatic accumulation of fibrin was determined by
immunofluorescence. LPS robustly increased hepatic fibrin deposition 8 hours after LPS
administration (Figure 3). Fibrin deposition was primarily located in the hepatic sinusoidal space.
As has been observed previously (2), ethanol pre-exposure enhanced the accumulation of fibrin
caused by LPS. CycloRGDN administration did not alter the effect of LPS or ethanol on fibrin
accumulation in mouse liver.

CycioRGOfV protects against enhanced liver injury and neutrophil infiltration.

LPS administration resulted in inflammatory focie in mouse liver compared to animals
(Figure 4). As has been observed previously, ethanol significantly increased the detrimental
effect of LPS as evidenced by necroinflammatory focie in the hepatic tissue of animals that
received the combination of ethanol and LPS. Administration of cycloRGDN blunted the effect of
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Figure 2: Effect of cycloRGDfV on integrin mRNA expression.
Male C57BLl6J mice were given ethanol or isocaloric, isovolumetric control diet 3
days and injected with LPS or saline vehicle either 8 or 24 h after the last dose of
ethanol, with some animals receiving cycloRGDN 1 h prior to LPS as described
in Methods. Hepatic mRNA expression of the av and ~3 integrin subunits were
determined by real time RT-PCR. Data are means ± SEM (N=4-6). ap <O.05
compared to maltose dextrin controls; bp <O.05 compared to LPS alone.
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Figure 3

Fibrin

Figure 3: Effect of cyc/oRGDfV on hepatic fibrin deposition.
Animals were treated as described in Methods.
Representative
photomicrographs (400x) of immunofluorescent detection of fibrin deposition at
the 8 hour time point are shown .
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Figure 4
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Figure 4: Effeet of eye/oRGDfV on liver injury.
Representative photomicrographs (200x; 400x insets) of hematoxylin & eosin
staining are shown (top panel). Inflammatory foci were seen in the liver of
animals that received LPS and a combination of ethanol , LPS , and cycloRGDN.
Necroinflammtory foci were observed in animals that received ethanol and LPS
without the integrin inhibitor. The plasma AL T and AST levels were analyzed by
spectrophotometric analysis (lower panels) . Data are means ± SEM (n = 4-6) .
ap <O .05 compared to MD controls ; bp <O .05 compared to LPS alone; cp <O .05
compared to LPS + ethanol.
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ethanol under these conditions and livers resembled those of animals exposed to LPS alone.
Administration of LPS alone significantly increased the number of infiltrating neutrophils 24 hours
after LPS administration (Figure 5). Ethanol pre-exposure enhanced the increase in neutrophil
migration caused by LPS by -2 fold. CycioRGDN blunted this effect of ethanol pre-exposure,
with the average number of infiltrating neutrophils in this group similar to those treated with LPS
alone. Ethanol pre-exposure enhanced liver injury due to LPS 24 hours after LPS administration,
as indicated by a significant increase in plasma ALT levels (Figure 4, bottom left). CycloRGDN
protected against enhanced levels of circulating transaminases, significantly blunting serum
levels of AL T and AST. There were no significant differences in serum levels of AL Tor AST or
gross liver morphology due to alcohol pre-exposure or cycioRGDN 8 hours after LPS (Figure 4,
bottom right) (2).

CycloRGDfV did not affect mRNA expression of cell adhesion and inflammatory genes.

In order to further evaluate the effect of cycioRGDN on inflammation in this model, hepatic
mRNA expression of a panel of inflammatory cytokines and cell adhesion proteins was
determined (Table 1). The pro-inflammatory cytokines TNFa and IL-6 as well as the antiinflammatory cytokine IL-10 were significantly increased in all groups compared to maltosedextrin fed controls by -50-, 150-, and 25-fold, respectively; cycioRGDN did not affect the
expression of TN Fa, IL-6, or IL-10 compared to animals that received LPS or a combination of
LPS and ethanol. PAI-1 expression was significantly increased in all groups compared to
controls. Expression of intracellular adhesion molecule-1 (ICAM-1) was significantly increased in
all groups compared to controls. The hepatic mRNA expression of the cell surface receptor
CD31 was significantly decreased by LPS administration compared to saline administration.
Ethanol preexposure and cycioRGDN did not significantly affect mRNA expression of CD31
compared to LPS alone. Integrins affect intracellular signaling via interaction with adaptor
proteins and kinases, including the integrin-linked kinase (ILK). Hepatic mRNA expression of the
integrin linked kinase (ILK) was significantly decreased in the groups that received LPS alone or
the combination of ethanol and LPS whereas animals receiving cylcoRGDN in combination with

13

Figure 5
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Table 1: Hepatic mRNA Expression. a indicates p>O.S compared to control;

b

indicates p>O.S compared to LPS
EtOH + LPS +
MD Control

MD + LPS

EtOH + LPS

RGDfV

8 hours

TNFalpha

1.0±O.37

42.9±8.Sa

a
4S.1±S.3

76.9±21.9a

IL-6

1.0±O.O8

131±1S.1a

138±23.2a

177±38.7a

IL-10

1.0±O.32

23.8±2.1a

a
26.37±3.8

26.7±S.Sa

PAI-1

1.0±O.43

a
1443±278

183S±210a

1327±296a

ICAM

1.0±O.24

a
10.6±1.8

11.3±1.2a

9.S±3.S

CD31

1.0±O.32

a
O.26±O.04

O.40±O.06a

O.40±O.07a

ILK

1.0±O.O6

O.3S±O.04

c-Fos

1.0±O.1S

1.2±O.16

1.11±O.17

2.2±1.02

c-Myc

1.0±O.19

2.3±O.3S

1.9±O.2S

1.7±O.24

SOCS3

1.0±O.23

4.0±O.S8

8.4±1.4a,b

S.4±O.94a,c

a

O.S6±O.08

a

a

O.69±O.1S

24 hours

c-Fos

1.0±O.O3

O.7S±O.14

1.6±O.14a,b

1.1±O.17c

c-Myc

1.0±O.21

O.97±.21

O.89±.O97

1.3±O.14

SOCS3

1.0±O.23

1.71±O.60

2.6±O.80

1.2±O.1S
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ethanol and LPS were protected from this decrease in ILK expression.

Endothelial cell dysfunction
Platelet endothelial cell adhesion molecule (CD31) is a cell surface receptor expressed
on endothelial cells which may be important in neutrophil migration as well as integrin activation
(26). The expression of CD31 was decreased by more than half in all groups compared to
controls (Table1). However, immunofluorescent staining for CD31 was increased by LPS, and
this increase was blunted by ethanol pre-exposure (Figure 6). CD31 expression in animals
administered cycloRGDN was greater than that in animals that received a combination of ethanol
and LPS without the drug. LPS exposure significantly elevated levels of circulating hyaluronic
acid (HA) (Figure 7). Neither ethanol preexposure nor cycloRGDN administration significantly
affected levels of HA compared to animals that received LPS alone.

Phosphorylation of signaling molecules downstream of integrin activation
Activation of integrins by extracellular ligands causes a rapid conformational change in
the cytosolic domain of the integrin's beta subunit allowing association of adaptor proteins and
activation of subsequent signaling cascades, including ERK and JNK (27). The phosphorylation
status of ERK1/2 and JNK1/2 were determined by Western blot (Figure 8). Phosphorylation of
ERK1/2 was significantly decreased in all groups compared to controls. Levels of phosphoJNK1/2 were not significantly affected by any treatment. To explore further the effect of blocking
integrin signaling, the phosphorylation status of the adaptor proteins focal adhesion kinase (FAK)
and paxillin was also determined. Phosphorylation of FAK was significantly decreased in all
experimental groups compared to controls (Figure 8). However, the phorphorylation status of
paxillin was not significantly affected in any of the treatment groups.

Effect of cycloRGDfV on STAT3 phosphorylation and STAT3 regulated genes
Despite no significant effect of ethanol pre-exposure or cycloRGDN on ligands of
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Figure 6

(D31
lPS

Figure 6: Effect of eye/oRGDfV on CD31 expression.
Hepatic CD31 expression was determined by immunofluorescent detection as
described in Methods. Representative photomicrographs (400x) of the 8 h time
point are shown.
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re 7:
Effect of RGDfV on plasma levels of hyaluronic acid (HA).
Plasma levels of HA were determined for the 8 hour time point as described in
Materials and Methods. Data are means ±SEM (n=4-6). ap <O.05 compared to
MD controls
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Figure 8
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Figure 8: Phosphorylation of signaling kinases and adaptor proteins.
Immunoblots were performed as described in Methods.
Representative
immunoblots for phosphorylated and total ERK, JNK, FAK, paxillin , and STAT3
for the 8 h time point are shown (top panel). Phosphorylated protein levels were
normalized to levels of total protein and quantified by densitometry. Data are
means ± SEM (n =4-6). ap <O .05 compared to MD controls.
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JAKISTAT signaling (i.e. IL-6; Table 1), expression of JAKISTAT responsive genes was
differentially affected by ethanol preexposure and cycloRGDN. Eight hours after LPS
administration, no significant changes were seen in mRNA expression of c-Myc or c-Fos,
however suppressor of cytokine signaling 3 (SOCS3) mRNA expression was significantly
increased in animals pre-exposed to ethanol compared to those administered LPS alone (Table
1). CycloRGDN administration blunted the increase in expression of SOCS3 caused by ethanol
preexposure followed by LPS. Whereas mRNA expression of SOCS3 and c-Myc were similar
across all groups 24 hours after LPS, expression of c-Fos was significantly increased by ethanol
pre-exposure compared to LPS alone. CycloRGDN attenuated this increase in c-Fos caused by
ethanol and LPS. The ratio of phosphorylated signal transducer and activator of transcription 3
(STAT3) to total STAT3 was significantly increased by LPS administration compared to maltosedextrin fed controls (Figure 8). Ethanol preexposure blunted this increase in STAT3
phosphorylation; cycloRGDN had no effect on phosphorylation of STAT3 compared to controls or
ethanol preexposed animals.

20

DISCUSSION
Previous studies from using this 2-hit model of liver injury have shown that hepatic fibrin
accumulation is correlated to liver injury and inflammation (2). Furthermore, enhanced LPSinduced liver injury and inflammation caused by alcohol was prevented by blocking fibrin
accumulation. Such studies suggested that fibrin plays a pro-inflammatory role in alcoholic liver
injury, however the mechanism by which fibrin mediates these effects remain unclear. The
experiments described here were performed to test the hypothesis that fibrin mediates proinflammatory effects in the liver via interaction with integrins, specifically integrin

av~3,

in a 2-hit

model of acute alcohol exposure.
While nearly all individuals who drink alcohol develop some degree of steatosis, only a
small fraction of alcoholics ever progress to steatohepatitis, a disease state characterized by
persistent inflammation and continued fat accumulation. One explanation for this phenomenon is
the 2-hit hypothesis proposed by Day and James (28). The 2-hit hypothesis suggests that ethanol
exposure is not sufficient for alcoholic liver disease, but rather that a second hit is required in
order for later stages of disease to develop. Thus, 2-hit models of liver injury, where ethanol
serves as the 'first hit' that sensitizes the liver to a 'second hit' such as LPS are commonly used
to study alcoholic liver disease. The acute 2-hit model (Figure 1) of alcohol exposure was chosen
for this study because the response to LPS with and without alcohol preexposure appears similar
mechanistically to certain aspects of alcohol-induced liver injury, specifically the inflammatory
phase of steatohepatitis. Indeed, although ethanol alone causes no gross morphological
changes in this model, it nevertheless robustly enhances liver injury caused by LPS (2).
The experiments described in this thesis were designed to study the role of the integrin
av~3

in enhanced LPS-induced liver injury after acute alcohol exposure. The integrin

av~3

was

specifically chosen for this study because of its proximity to fibrin ECM molecules and ability to
bind RGD-containing ECM components including fibrin. Indeed, integrin
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av~3

is expressed by

sinusoidal endothelial cells which line the sinusoids where fibrin accumulates in the acute 2-hit
model of alcohol exposure used for this study. Additionally, others have shown the integrin av133
binds fibrin (5). The interaction between RGD-containing ECM components, such as fibrin, and
the integrin av133 can be studied using commercially available peptide antagonists such as
cycloRGDN. CycloRGDN is a small cyclic peptide that binds the av133 integrin, preventing the
integrin's interaction with other molecules. CycloRGDN was chosen for use in this study
because of its relative specificity for integrin avl33.
As expected, LPS administration significantly increased fibrin deposition (Figure 3), liver
damage (Figure 4) and liver inflammation (Figure 5), all of which were enhanced by alcohol
preexposure. Animals that received cycloRGDN were protected against enhanced liver injury
and inflammation, but had fibrin deposition similar to animals that received only ethanol and LPS.
These observations support our hypothesis and show that the protection conferred by
cycloRGDN was independent of the magnitude of fibrin deposition. Protection was also
independent of integrin expression (Figure 2), suggesting that the protective mechanism(s) at
work in this model are 'downstream' of the ligand and receptor required for integrin activation, per
se.
Dysregulated immune response after alcohol exposure is known to contribute to the
pathogenesis of ALD. Indeed, alcohol exposure can cause changes in the expression of
inflammatory mediators favoring a pro-inflammatory profile that allows for normal tissue damage.
For example, alcohol increases circulating levels of endotoxin (29) and sensitizes Kupffer cells,
the resident macrophages of the liver, to stimulation by LPS (30). Moreover, sensitization of
Kupffer cells by ethanol can result in enhanced release of pro-inflammatory mediators including
TNFa (31). The release of TN Fa can result in recruitment and activation of other cells of the
innate immune system, promoting necrotic cell death, such as that observed in animals that
received a combination of ethanol and LPS in this study. Indeed mRNA expression of TN Fa, a
pro-inflammatory cytokine released from activated Kupffer cells, was significantly increased by
more than 40-fold in all groups compared to controls. Additionally, neutrophil count correlated to
severity of liver injury with alcohol preexposure enhancing both injury and neutrophil count.

22

CycioRGON attenuated these detrimental effects of alcohol preexposure. These results suggest
that the integrin antagonist may protect against liver injury by blunting the enhanced LPS-induced
inflammatory response that occurs after ethanol preexposure.
One mechanism by which cycioRGON may protect against inflammatory injury is by
attenuating the increase in inflammatory mediators caused by alcohol preexposure. Indeed,
protecting against increased levels of inflammatory mediators can protect against hepatic injury
after alcohol exposure. However, cycioRGON did not differentially affect hepatic levels of the
proinflammatory mediators TNF-a, IL-6, PAI-1 or the antiinflammatory cytokine IL-10. In fact, all
groups had increased hepatic mRNA expression of TNF-a, IL-6, PAI-1, and IL-10 compared to
controls (Table 1). These results demonstrate that the protective effects of cycioRGON were
independent of changes in the mRNA expression of inflammatory mediators investigated in this
study.
Protection against enhanced inflammation in this model was indicated by Significantly
fewer neutrophils in the liver tissue of animals that received cycioRGON in addition to ethanol
and LPS compared to those that received the combination of ethanol and LPS without the integrin
antagonist. Infiltration of neutrophils and other inflammatory cells into tissue is mediated by cellsurface receptors. For example, ICAM-1, a cell surface adhesion receptor expressed by
endothelial cells, interacts with neutrophil-specific receptors to allow for neutrophil chemotaxis.
The mRNA expression of ICAM-1 was Significantly increased in all groups compared to controls
and was not differentially affected by cycioRGON administration. C031, also known as plateletendothelial cell adhesion factor (PECAM), is a cell surface receptor expressed by sinusoidal
endothelial cells (SECSs) and neutrophils (32) which has been linked to integrin activation (33).
C031 receptors expressed on SECs can facilitate neutrophil transmigration via homophilic
interactions with C031 receptors on immune cells such as neutrophils (12, 34). The mRNA
expression of C031 was significantly decreased in all groups compared to controls. In contrast,
protein expression of C031 in hepatic tissue was increased by LPS administration (Figure 6).
Ethanol preexposure caused a robust decrease in C031 expression compared to LPS alone.
This decrease in C031 expression caused by ethanol preexposure suggests that the enhanced
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neutrophil migration caused by ethanol after an inflammatory stimulus was not a result of
increased CD31-mediated neutrophil migration. CycloRGDN increased CD31 expression
compared to ethanol + LPS. ConSidering the proinflammatory role of CD31 in neutrophil
migration, increased CD31 expression caused by cycloRGDN administration would be expected
to correlate with increased neutrophil migration into tissue, the opposite of what was observed in
this study. In fact, cycloRGDN attenuated the increase in neutrophil migration caused by ethanol
preexposure (Figure 5). Recent studies have shown that CD31 can facilitate neutrophil migration
via heterophilic interactions with other cell surface receptors, including integrin av~3 (33) (Figure
9, top panel). Indeed, blocking heterophilic interactions between CD31 and integrins can prevent
neutrophil migration mediated by these interactions. In this study, the integrin antagonist
cycloRGDN was used to block ECM-integrin av~3 interactions. However, cycloRGDN may have
additionally blocked CD31-integrin avj33 interactions, preventing neutrophil migration mediated by
such heterophilic interactions (Figure 9, bottom panel). This mechanism could explain the
decrease in neutrophils in the liver tissue due to cycloRGDN despite increased hepatic CD31
expression in these animals.
CD31 also has potent anti-inflammatory roles; its expression has been shown to be
protective against LPS-induced endotoxemia (35, 36).

It comprises the majority of intracellular

junctions of endothelial cells (37) and can mediate anti-inflammatory effects by maintaining
vascular integrity (26). Additionally, increased CD31 expression on SECs indicates
angiogenesis, which is important for recovery after liver injury. In this study, hepatic expression
of CD31 was decreased by ethanol exposure and rescued by cycloRGDN administration.
Reduction in CD31 expression in ethanol preexposed mice may indicate reduced vascular
integrity and/or angiogenesis, two factors necessary for restoration of damaged hepatic tissue.
CycloRGDN rescued CD31 expression. Thus, enhanced liver injury caused by alcohol exposure
in this model may be due, at least in part, to an inability to recover after inflammatory insult.
Furthermore, protection conferred by cycloRGDN may be a result of increased vascular integrity
and angiogenesis which allowed for hepatic recovery.
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Figure 9
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Figure 9. Heterodimeric interactions of CD31 with integrin aVf33. CD31
expressed on neutrophils has been shown to interact with the integrin av133
expressed on endothelial cells. Interaction between CD31 and integrin av133
allows for transmigration of neutrophils into tissue. One mechanism by which
cycloRGDN may attenuate neutrophil migration into liver tissue is by blocking
heterodimeric intearctions between CD31 and integrin avl33.
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Previously published data using this model of alcohol exposure showed that increased
activation of ERK1/2 4 h after LPS administration occurs downstream of TNFa and mediates
increased PAI-1 expression and subsequent fibrin accumulation in the liver (2). Interestingly,
integrin activation can also activate ERK signaling via changes in the phosphorylation status of
various adaptor proteins (11). Whereas TNFa and PAI-1 mRNA expression were still significantly
increased 8 hours after LPS administration in this study (Table 1), ERK1/2 phosphorylation was
reduced in all groups compared to controls at this time point (Figure 8). Because activation of
ERK1/2 can occur downstream of adaptor proteins that associate with the cytosolic domains of
activated integrins, the phosphorylation status of FAK was determined. FAK is an integrin-linked
adaptor protein that can contribute to activation of ERK signaling downstream of integrin
activation (12). Phosphorylation of FAK was significantly decreased in all groups compared to
controls; however neither ethanol preexposure nor cycloRGDN administration had additional
effects on FAK phosphorylation (Fig. 8). Decreased FAK phosphorylation could account for the
decrease in ERK1/2 signaling seen in our model, but not for the protective effects of cycloRGDN.
Reduced FAK phosphorylation may also account for the decrease in phosphorylation of JNK
which occurs downstream of FAK activation (27). However, changes in the phosphorylation
status of these adaptor proteins and kinases cannot account for the protective effects of
cycloRGDN in this model.
Previous studies from this group have suggested a possibility for cross-talk between IL-6
receptor signaling and integrin signaling via STAT3 (Figure 10). JAK-STAT Signaling pathways
are activated by a myriad of extracellular signaling molecules, including IL-6. The JAK-STAT
pathway has also been shown to be activated by other integrins (38). Upon binding of IL-6 to the
IL-6 receptor (IL-6R), JAK undergoes autophosphorylation, allowing for the binding of and
subsequent phosphorylation of STAT3. Although hepatic IL-6 mRNA expression was significantly
increased in all groups, STAT3 phosphorylation was not Significantly affected by LPS, ethanol, or
cycloRGDN compared to controls. The mRNA expression of the STAT3-responsive genes cFos, c-Myc, and SOCS3 was also determined. HepatiC c-Fos expression was significantly
increased by ethanol pre-exposure, but blunted by cycloRGDN. C-Fos has been shown to
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Figure 10. Intracellular signaling downstream of integrin activation. Ethanol
enhances increased fibrin deposition due to LPS . Fibrin is associated with proinflammatory effects, possibly by activating integrins via its RGD sequence.
Integrin activation triggers a myriad of intracellular signaling events including the
phosphorylation of adaptor proteins (e.g . FAK, and paxillin) . Adaptor proteins
facilitate activation of signaling cascades including MAPK and JNK and possibly
crosstalk with IL-6 signaling via STAT3 activation.
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mediate LPS-induced liver injury by increasing hepatic levels of proinflammatory chemokines (i.e.
MIP-1a and MCP-1) (39). Therefore, blocking enhanced c-Fos expression could provide
protection in this model. SOCS3 expression was differentially affected by ethanol pre-exposure
and cycioRGON with integrin inhibition protecting against enhanced mRNA expression of SOCS3
due to ethanol preexposure.
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SUMMARY AND CONCLUSIONS

STRENGTHS OF THIS WORK
This work has many strengths. First, it identifies a new player, integrin avl33, in alcoholic
liver disease. Currently, no FDA approved therapy exists to halt or reverse alcoholic liver
disease. In order for new therapies to be developed, new key players must be identified as
potential therapeutic targets. This work suggests that integrin inhibitors, some of which have
already been studied in clinical trials for asthma and chronic obstructive pulmonary disease (16)
as well as cancer therapies (17), may also be beneficial in treating ALD. More specifically,
inhibitors of the integrin av133may be particularly useful in the inflammatory phases of liver injury
such as steatohepatitis.
All the work described here was performed in the whole animal. Use of the whole animal
is particularly important when studying diseases that involve multiple organs, such as ALD.
Indeed, although in vitro studies using single cell culture or co-culture are useful, whole animals
experiments allow better translation to the human disease. Additionally, this study used a specific
peptide inhibitor of integrin avl33, cycloRGDN. The use of a pharmacological inhibitor provides
advantages over a whole mouse deletion of the avl3 integrin. Whole mouse deletions can result
in non-specific effects due to compensatory mechanisms that are selected for early in
development. Deletion of the 133 integrin subunit is highly lethal, and while some animals do
survive to adulthood, the adult population of this strain of mouse may have compensatory
mechanisms at work.
For these studies, an acute model of alcohol-induced liver injury was used. While no
model fully recapitulates the human disease, this model does provide a number of advantages
over other alcohol feeding models. For example, in this model, the experimenter can control how
much and when the animals ingest ethanol to ensure all animals receive similar concentrations of
ethanol and reach similar states of inebriation.
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CAVEATS AND WEAKNESSES

The main purpose of this work was to investigate the role of integrin av(33 in a model of
enhanced LPS-induced liver injury caused by alcohol. In order to study the effects of inhibiting
integrin av(33, a commercially available peptide inhibitor, cycloRGDN, was used. While use of
this inhibitor conveyed some advantages to this study, cycloRGDN may interact with other
integrins that recognize RGD sequences. Furthermore, a variety of integrins recognize RGD
sequences that could also interact with the RGD sequences of fibrin. Therefore, we cannot
conclusively state that the specific interaction between av(33 and fibrin is the mechanism at work
under these conditions. This study also did not offer insight into which cells are being primarily
affected by cycloRGDN administration. Nearly all cells express a number of different integrin
heterodimers and a single integrin can be expressed by a variety of cell types, for instance the
integrin of primary interest in this study, av(33, is known to be expressed on SECS, Kupffer cells,
neutrophils, and platelets. Additional studies would be required to examine more specifically the
ECM-integrin interactions that are key to protection in this model.
This study was conducted in an acute alcohol exposure model that enhances liver injury
due to LPS. While this model has advantages (see Strengths), it does not fully recapitulate
alcohol exposure in humans. This model requires forced feeding of alcohol to overcome rodents'
natural aversion to ethanol, which prevents them from voluntarily consuming enough toxin to
cause liver damage. Although this acute model of exposure has advantages, most liver damage
is associated with chronic alcohol exposure. Therefore, effects found in this model do not
necessarily recapitulate the chronic disease. However, recent studies suggest that a critical
component of ALD may be 'acute on chronic' drinking behavior in which chronic alcoholics binge
periodically. Additionally, acute models have proven to be a useful screening to complement
chronic studies. Indeed, there is great mechanistic overlap of protective agents used in both
acute and chronic models and, to date, there have been no 'false positives' observed when
studying protective agents in acute models of alcohol exposure (40-42). This model recapitulates
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the inflammatory aspects of the pre-fibrotic stages of alcoholic liver disease, mainly chronic
inflammation. While the mechanisms involved in various stages of alcohol-induced liver injury
have been extensively investigated, the mechanism behind progression from earlier stages of
ALD (i.e. steatosis) to later stages, such as steatohepatitis, remain unclear.

Accordingly, a

major goal of this work was to identify key players in earlier, highly reversible stages of the
disease with an emphasis on the inflammatory response characteristic of steatohepatitis and is
the justification for using the model for this study.

FUTURE DIRECTIONS
The future directions described here are to address the issues discussed in Caveats and
Weaknesses and the questions that remain unanswered with regard to the role of integrins in
alcohol-induced organ injury. The purpose of the experiments described herein would be to build
on the theme of this thesis, but are not necessary to complete this project.

Role of integrins in animal models of chronic alcohol exposure.
This study provides compelling evidence indicating that blocking integrin activation protects
against enhanced LPS-induced liver injury caused by acute alcohol exposure, However, the role
of

~3-containing

integrins after chronic alcohol exposure remains unknown. While the model used

in this study recapitulates the chronic inflammation characteristic of pre-fibrotic stages of liver
injury, steatosis does not persist in this model. Acute models of alcohol exposure are convenient
and allow for more precise control over timing and extent of inebriation, however chronic models
of alcohol exposure better recapitulate the human condition. The role of

~3-containing

integrins

in alcohol-induced organ injury could be investigated further using a chronic model of alcohol
exposure and ~3-1- mice.

A whole animal knockout would be advantageous in a chronic model of

alcohol exposure in order to ensure that activity of

~

subunit-containing integrins is inhibited

throughout the duration of the study.

Do integrins mediate susceptibility to injury in the alcoholic lung?
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Integrins have also been shown to playa role in enhanced susceptibility to lung injury
caused by alcohol exposure. Alcohol is known to sensitize to acute lung injury (43, 44). These
effects may be due to a myriad of changes that occur after ethanol exposure and are similar to
changes seen in alcohol-induced liver injury and include altered inflammatory response, oxidative
stress, and tissue remodeling. Several key players that this group has identified in liver injury
also appear to play important roles in the alcoholic lung. For example, LPS enhances injury due
to ethanol in both organs (45). Additionally, fibrin mediates pro-inflammatory effects in lung (46).
These observations further support the possibility of mechanistic overlap of alcohol-induced injury
in these two organs. Therefore, it would be pertinent to determine if 133 containing integrins may
mediate inflammation downstream of tissue remodeling in the lung. The role of integrins in
enhanced susceptibility to pulmonary injury due to alcohol could be studied in a chronic alcohol 2hit model of organ injury using whole mouse knockouts of the
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133 integrin subunit.
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ABBREVIAnONS
ALD

Alcoholic Liver disease

ALT

Alanine aminotransferase

AST

Aspartate aminotransferase

CAE

Chloroacetate esterase

CD31

Platelet-endothelial cell adhesion molecule (PECAM)

ERK

Extracellular signal-related kinases 1/2

EtOH

Ethanol

FAK

Focal adhesion kinase

GAPDH

Glyceraldheyde 3-phosphate dehydrogenase

H&E

Hematoxylin & eosin

HA

Hyaluronic acid

ICAM

Intracellular adhesion molecule

IL-10

Interlukin-10

IL-6

Interlukin-10

ILK

Integrin-linked kinase

JAK

Janus kinase

JNK

c-Jun N-terminal kinase

LPS

Lipopolysaccharide

MAPK

Mitogen-activated protein kinase
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MD

Maltose-dextrin

PAI-1

Plasminogen activator inhibitor-1

SEC

Sinusoidal endothelial cell

SOCS3

Suppressor of cytokine signaling-1

STAT3

Signal transducers and activators of transcription 3

TNFa

Tumor necrosis factor-alpha
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